Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
European Study of POBA Versus Cotavance(R) Paclitaxel Coated Balloon for the Treatment of Infrapopliteal Lesions in Critical Limb Ischemia (EURO CANAL)
This study is currently recruiting participants.
Verified July 2012
by MEDRAD, Inc.
Study NCT01260870 Information provided by MEDRAD, Inc.
First Received on December 13, 2010. Last Updated on July 10, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Cotavance Paclitaxel Coated Balloon
Standard balloon angioplasty
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Antineoplastic Agents, Phytogenic
Molecular Mechanisms of Pharmacological Action
Sponsors listed in this trial
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers